ABBV vs TTD: Which Is the Better Buy?
Side-by-side comparison of AbbVie Inc. and The Trade Desk, Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-18.
AbbVie Inc. · Healthcare
$261.70
-1.0% upside to fair value
Med Conviction
Grade C
High Quality
VS
The Trade Desk, Inc. · Communication Services
$14.26
-1.8% upside to fair value
Med Conviction
Grade C
High Quality
QuantHub Verdict
ABBV has more upside to fair value
(-1.0%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
ABBV |
TTD |
| Current Price |
$261.70 |
$14.26 |
| Fair Value Estimate |
$259.04 |
$14.00 |
| Upside to Fair Value |
-1.0%
|
-1.8%
|
| Market Cap |
$462.4B |
$6.7B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
24.8x
|
7.5x
|
| Price / Sales |
7.2x
|
2.2x
|
| Price / FCF |
23.6x
|
7.8x
|
| Revenue Growth YoY |
+10.2%
|
+3.0%
|
| Gross Margin |
71.5%
|
83.0%
|
| Operating Margin |
29.3%
|
19.6%
|
| Return on Equity |
-136.5%
|
16.1%
|
| Dividend Yield |
2.61% |
0% |
| FCF Yield |
4.25%
|
12.89%
|
| Analyst Consensus |
Strong Buy
|
Hold
|
Investment Thesis
AbbVie is a diversified branded-biopharma company spanning immunology, neuroscience, oncology and aesthetics, with high-margin TTM economics including a 71.5% gross margin and 29.3% operating margin. Its successor immunology franchises are performing strongly: Q2 2026 revenue rose 10.2% year over year, with Skyrizi up 24.4% to $5.505 billion and Rinvoq up 24.5% to $2.525 billion, helping offset a…
The Trade Desk operates a self-service, cloud-based demand-side platform that lets advertising agencies and their advertiser clients plan, buy and optimize data-driven digital campaigns across display, video, audio, native, social and connected TV, with 3,843 employees and a founder-led management team. Business quality is genuinely high on the unit economics: TTM gross margin of 83.0%, TTM opera…
Accumulation Zones
| Metric |
ABBV |
TTD |
| Zone Low |
$194.28 |
$10.50 |
| Zone High |
$220.18 |
$11.90 |
| In Buy Zone? |
No
|
No
|